These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9666592)

  • 1. [Meningitis caused by Pseudomonas aeruginosa. Treatment with meropenem].
    Barberán J; García MC; Campos A; Khorrami S
    Enferm Infecc Microbiol Clin; 1998 May; 16(5):249. PubMed ID: 9666592
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacterial meningitis and Pseudomonas aeruginosa: apropos of a case].
    Batlle Almodóvar Mdel C; Dickinson F; Pérez Monrás M; Tamargo Martínez I; Similis A
    Rev Cubana Med Trop; 2005; 57(3):230-2. PubMed ID: 17969281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraventricular antibiotic therapy].
    Thilmann AF; Möbius E; Podoll K
    Nervenarzt; 1992 Feb; 63(2):108-12. PubMed ID: 1565167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem treatment of meningitis.
    Klugman KP; Dagan R
    Scand J Infect Dis Suppl; 1995; 96():45-8. PubMed ID: 7652503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult Pseudomonas aeruginosa meningitis: high incidence of underlying medical and/or postneurosurgical conditions and high mortality rate.
    Huang CR; Lu CH; Chuang YC; Tsai NW; Chang CC; Chen SF; Wang HC; Chien CC; Chang WN
    Jpn J Infect Dis; 2007 Nov; 60(6):397-9. PubMed ID: 18032844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa causing nosocomial meningitis in neonates and children: overview of 15 cases within 10 years.
    Ondrusova A; Kalavsky E; Rudinsky B; Freybergh FP; Bauer F; Miklosko J; Huttova M; Kisac P; Cauda R
    Neuro Endocrinol Lett; 2007 Jun; 28 Suppl 2():20-1. PubMed ID: 17558370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filamented Pseudomonas aeruginosa and a markedly high level of endotoxin in cerebrospinal fluid.
    Kawano C; Muroi K; Yozhizawa M; Kirikae T; Ozawa K
    J Infect; 2000 Jul; 41(1):114-5. PubMed ID: 10942652
    [No Abstract]   [Full Text] [Related]  

  • 8. Meropenem treatment of post-traumatic meningitis due to Pseudomonas aeruginosa.
    Chmelik V; Gutvirth J
    J Antimicrob Chemother; 1993 Dec; 32(6):922-3. PubMed ID: 8144444
    [No Abstract]   [Full Text] [Related]  

  • 9. Repeated relapses in a meropenem-treated Pseudomonas aeruginosa meningitis.
    Esen S; Leblebicioglu H; Sunbul M; Eroglu C
    J Chemother; 2002 Oct; 14(5):535-6. PubMed ID: 12462436
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrathecal amikacin for the treatment of pseudomonal meningitis.
    Corpus KA; Weber KB; Zimmerman CR
    Ann Pharmacother; 2004 Jun; 38(6):992-5. PubMed ID: 15122005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of Acinetobacter meningitis with meropenem and rifampicin.
    Gleeson T; Petersen K; Mascola J
    J Antimicrob Chemother; 2005 Sep; 56(3):602-3. PubMed ID: 16046467
    [No Abstract]   [Full Text] [Related]  

  • 12. The green cerebrospinal fluid.
    Escota G; Como J; Kessler H
    Am J Med; 2011 May; 124(5):411-3. PubMed ID: 21531229
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudomonas cepacia meningitis: report of 3 cases].
    Takagi T; Nagai H; Kobayashi M; Shinagawa N
    No Shinkei Geka; 1982 Jan; 10(1):83-8. PubMed ID: 7078698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Normal cerebrospinal fluid in clinically suspected bacterial meningitis].
    Gonera-de Jong BC; Kabel PJ; Peeters MF; Draaisma JM
    Ned Tijdschr Geneeskd; 1994 Oct; 138(41):2033-5. PubMed ID: 7935964
    [No Abstract]   [Full Text] [Related]  

  • 16. Empirical treatment of adult postsurgical nosocomial meningitis.
    De Bels D; Korinek AM; Bismuth R; Trystram D; Coriat P; Puybasset L
    Acta Neurochir (Wien); 2002 Oct; 144(10):989-95. PubMed ID: 12382127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapy.
    Santos Filho L; Eagye KJ; Kuti JL; Nicolau DP
    Clin Microbiol Infect; 2007 Jun; 13(6):579-85. PubMed ID: 17331121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
    Metan G; Alp E; Aygen B; Sumerkan B
    Int J Antimicrob Agents; 2007 Jan; 29(1):112-3. PubMed ID: 17134880
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of meropenem in experimental meningitis.
    Nairn K; Shepherd GL; Edwards JR
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():73-84. PubMed ID: 8543501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation.
    Lee AB; Harker-Murray P; Ferrieri P; Schleiss MR; Tolar J
    Pediatr Blood Cancer; 2008 Mar; 50(3):673-6. PubMed ID: 17588235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.